title: Predictors of pregnancy in microbicide trials.
abstract: BACKGROUND
  High pregnancy rates undermine the conduct and interpretation of HIV prevention trials. We performed this analysis to identify baseline participant characteristics associated with increased risk of pregnancy in recent vaginal microbicide trials.
  
  
  METHODS
  We analyzed the data from four recently completed Phase III trials of candidate microbicides for prevention of HIV infection. Cox proportional hazard models, stratified by site nested within study, were used to determine the baseline factors that predict pregnancy. Six thousand seven hundred forty-eight women contributed data for this analysis.
  
  
  RESULTS
  Pregnancies were detected in a total of 1826 (27.1%) women. The hazard of pregnancy was higher for women who had a history of pregnancy, were living with a man or reported more sexual acts not protected by condoms in the week prior to enrollment. The risk of pregnancy was lower in older participants; in women with more years of education; in women who reported more sexual partners at baseline interview; in women who reported using intrauterine contraception, implants, sterilization or injectables and in women who reported use of a condom during their last act of vaginal intercourse.
  
  
  CONCLUSIONS
  Our data suggest that current use or acceptance of intrauterine contraception, implants, sterilization or injectables is the most effective approach to reduce pregnancy rates and might be a useful eligibility criterion in future HIV prevention trials.
authors.affiliation: FHI, P.O. Box 13950, Research Triangle Park, NC 27709, USA. vhalpern@fhi.org
authors.forename: Vera
authors.initials: V
authors.lastname: Halpern
authors.forename: Che-Chin
authors.initials: CC
authors.lastname: Lie
authors.forename: Paul
authors.initials: P
authors.lastname: Feldblum
authors.forename: Lut
authors.initials: L
authors.lastname: Van Damme
mesh_terms: D000293:Adolescent; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D003267:Contraception / Q000379:methods*; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control* / Q000821:virology; D055815:Young Adult
chemical_list: D019380:Anti-HIV Agents